CytRx Using Forum Flip-Flop To Stall Del. Case, Investors Say
Counsel for a class of Delaware-based investors in biopharmaceutical firm CytRx Corp. urged the Chancery Court to keep their derivative action moving on Monday, saying the case raises unprecedented questions about...To view the full article, register now.
Already a subscriber? Click here to view full article